Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Multiple Myeloma 3 Lymphoma 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Abortion, Spontaneous 2 Wilms Tumor 1

Interventions

Dexamethasone 11 Bortezomib 7 Cyclophosphamide 6 Lenalidomide 5 pomalidomide 3 isatuximab 3 Kidney Transplantation 3 Calcium Dobesilate 3 glucarpidase 2 Thalidomide 2 Gemcitabine 2 Bendamustine Hydrochloride 2 Azacitidine 2 vinflunine 1 trifluridine tipiracil drug combination 1 trebananib 1 safinamide 1 sacubitril and valsartan sodium hydrate drug combination 1 rubitecan 1 ripretinib 1 regorafenib 1 pevonedistat 1 pembrolizumab 1 mirabegron 1 gamma-Glutamyl Hydrolase 1 gallium 68 PSMA-11 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03234335 2023-05-06

IRMYG

Centre Hospitalier Universitaire de Saint Etienne

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡